China Huntingtons Disease Treatment Market Size & Outlook
China huntingtons disease treatment market, 2018-2030 (US$M)
Related Markets
China huntingtons disease treatment market highlights
- The China huntingtons disease treatment market generated a revenue of USD 1.8 million in 2023 and is expected to reach USD 11.6 million by 2030.
- The China market is expected to grow at a CAGR of 30.2% from 2024 to 2030.
- In terms of segment, symptomatic treatment was the largest revenue generating treatment in 2023.
- Symptomatic Treatment is the most lucrative treatment segment registering the fastest growth during the forecast period.
Huntingtons disease treatment market data book summary
| Market revenue in 2023 | USD 1.8 million |
| Market revenue in 2030 | USD 11.6 million |
| Growth rate | 30.2% (CAGR from 2023 to 2030) |
| Largest segment | Symptomatic treatment |
| Fastest growing segment | Symptomatic Treatment |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Symptomatic Treatment |
Other key industry trends
- In terms of revenue, China accounted for 0.4% of the global huntingtons disease treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan huntingtons disease treatment market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 7.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Huntingtons Disease Treatment Market Scope
Huntingtons Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China huntingtons disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to huntingtons disease treatment market will help companies and investors design strategic landscapes.
Symptomatic treatment was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the China huntingtons disease treatment market based on symptomatic treatment covering the revenue growth of each sub-segment from 2018 to 2030.
The market is anticipated to witness growth owing to various factors such as launch of products, growing research initiatives, and increasing government funding for development of novel products. However, prevalence of HD is relatively lower than that in European countries.
In May 2020, Teva Pharmaceutical Industries Ltd. received NMPA approval for Austedo for treating chorea associated with HD. In April 2019, University of Plymouth received research funding of USD 146,878.53 from the UK for research collaboration toward finding a novel treatment strategy for HD.
Under this academic collaboration, a team of researchers of Fudan University, Shanghai will work together with University of Plymouth. Such research funding and initiatives are expected to boost market growth during the forecast period.
Reasons to subscribe to China huntingtons disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China huntingtons disease treatment market databook
-
Our clientele includes a mix of huntingtons disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China huntingtons disease treatment market , including forecasts for subscribers. This country databook contains high-level insights into China huntingtons disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China huntingtons disease treatment market size, by treatment, 2018-2030 (US$M)
China Huntingtons Disease Treatment Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
